Whit Mayo
Stock Analyst at Leerink Partners
(2.49)
# 2,436
Out of 5,006 analysts
151
Total ratings
51.55%
Success rate
10.33%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $17.64 | -3.63% | 11 | Sep 5, 2025 | |
ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $349.94 | -11.41% | 4 | Jul 18, 2025 | |
AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $8.18 | -69.44% | 5 | Mar 31, 2025 | |
AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $8.96 | +22.77% | 11 | Feb 13, 2025 | |
EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $8.14 | -1.72% | 2 | Nov 19, 2024 | |
ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $14.40 | +73.61% | 2 | Nov 12, 2024 | |
HUM Humana | Downgrades: Market Perform | $400 → $250 | $295.20 | -15.31% | 12 | Oct 2, 2024 | |
EHC Encompass Health | Initiates: Outperform | $100 | $123.62 | -19.11% | 1 | Jul 10, 2024 | |
BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $28.87 | -48.04% | 1 | Feb 20, 2024 | |
UNH UnitedHealth Group | Maintains: Outperform | $625 → $560 | $358.77 | +56.09% | 11 | Jun 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $206.84 | - | 11 | May 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $116.90 | -17.02% | 1 | Apr 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $302.99 | +10.56% | 5 | Feb 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $433.55 | -34.03% | 17 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $20.39 | +96.17% | 7 | Nov 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $24.13 | +61.62% | 7 | Nov 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.62 | -42.75% | 4 | Nov 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $1.12 | +2,578.57% | 5 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $199.76 | -72.47% | 14 | Oct 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $26.46 | +289.27% | 10 | Aug 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $93.71 | +86.75% | 1 | Apr 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $17.11 | +11.05% | 1 | Apr 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.09 | +29.45% | 6 | Jul 30, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $275.05 | -26.20% | 2 | May 1, 2018 |
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $17.64
Upside: -3.63%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $349.94
Upside: -11.41%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $8.18
Upside: -69.44%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $8.96
Upside: +22.77%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $8.14
Upside: -1.72%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $14.40
Upside: +73.61%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $295.20
Upside: -15.31%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $123.62
Upside: -19.11%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $28.87
Upside: -48.04%
UnitedHealth Group
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $358.77
Upside: +56.09%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $206.84
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $116.90
Upside: -17.02%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $302.99
Upside: +10.56%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $433.55
Upside: -34.03%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $20.39
Upside: +96.17%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $24.13
Upside: +61.62%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.62
Upside: -42.75%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $1.12
Upside: +2,578.57%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $199.76
Upside: -72.47%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $26.46
Upside: +289.27%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $93.71
Upside: +86.75%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $17.11
Upside: +11.05%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.09
Upside: +29.45%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $275.05
Upside: -26.20%